Russell Investments Group, Ltd. - PROTHENA CORP PLC ownership

PROTHENA CORP PLC's ticker is PRTA and the CUSIP is G72800108. A total of 158 filers reported holding PROTHENA CORP PLC in Q4 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of PROTHENA CORP PLC
ValueSharesWeighting
Q2 2024$36,141
+1022.4%
1,751
+1246.9%
0.00%
Q1 2024$3,220
-76.8%
130
-66.0%
0.00%
Q4 2023$13,881
-98.8%
382
-98.4%
0.00%
-100.0%
Q4 2021$1,171,000
+370.3%
23,711
+578.2%
0.00%
Q3 2021$249,000
-84.8%
3,496
-94.6%
0.00%
-100.0%
Q1 2021$1,634,000
+46.9%
65,119
-29.7%
0.00%
+50.0%
Q4 2020$1,112,000
+15.8%
92,656
-3.8%
0.00%0.0%
Q3 2020$960,000
-17.7%
96,293
-13.8%
0.00%
-33.3%
Q2 2020$1,166,000
+16.7%
111,734
+19.5%
0.00%0.0%
Q1 2020$999,000
-21.6%
93,518
+16.0%
0.00%
+50.0%
Q4 2019$1,275,000
+197.9%
80,613
+47.6%
0.00%
+100.0%
Q3 2019$428,000
-36.2%
54,600
-14.0%
0.00%0.0%
Q2 2019$671,000
-29.8%
63,464
-19.5%
0.00%
-50.0%
Q1 2019$956,000
+61.2%
78,851
+37.0%
0.00%
+100.0%
Q4 2018$593,000
-12.3%
57,550
+11.3%
0.00%0.0%
Q3 2018$676,000
+44.8%
51,711
+61.3%
0.00%0.0%
Q2 2018$467,000
-60.3%
32,0640.0%0.00%
-50.0%
Q1 2018$1,177,000
+40.1%
32,064
+45.0%
0.00%
+100.0%
Q4 2017$840,000
-65.2%
22,109
-40.8%
0.00%
-75.0%
Q3 2017$2,417,000
+31.8%
37,325
+10.2%
0.00%
+33.3%
Q2 2017$1,834,000
+173.3%
33,876
+181.6%
0.00%
+200.0%
Q1 2017$671,000
+27.1%
12,030
+12.8%
0.00%0.0%
Q4 2016$528,00010,6610.00%
Other shareholders
PROTHENA CORP PLC shareholders Q4 2017
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 9,426,640$73,905,0009.33%
GREAT POINT PARTNERS LLC 2,066,041$16,198,0001.49%
LONESTAR CAPITAL MANAGEMENT LLC 300,000$2,352,0000.78%
TANG CAPITAL MANAGEMENT LLC 423,823$3,323,0000.57%
Palo Alto Investors LP 1,004,449$7,875,0000.52%
Orbimed Advisors 3,022,117$23,693,0000.45%
Kerrisdale Advisers, LLC 61,640$483,0000.30%
Endurant Capital Management LP 86,407$677,0000.24%
Campbell & CO Investment Adviser LLC 47,901$376,0000.14%
Boxer Capital, LLC 79,598$624,0000.04%
View complete list of PROTHENA CORP PLC shareholders